The research listed on this page is focused upon the basic science and efficacy of cognitive therapy for schizophrenia.
Cognitive Therapy for Negative Symptoms and Functioning
Investigators: Aaron T. Beck, M.D., Paul M. Grant, Ph.D. and Neal M. Stolar, M.D.-Ph.D.
Project Director: Dimirti Perivoliotis, Ph.D.
Negative symptoms of schizophrenia (reduced verbal and nonverbal expressivity, limited engagement in constructive, pleasurable, and social activity) respond poorly to treatment and predict much of the disability associated with the disorder. While cognitive therapy (CT) has shown promise as an adjunctive intervention for negative symptoms, these symptoms were not the targets of previous psychosocial interventions. The present study is a randomized controlled trial designed to determine the efficacy of a cognitive therapy package specifically tailored to negative symptoms. The year-long intervention is goal-oriented and aims to help participants move to the next level, both socially and vocationally, while coping better with hallucinations, delusions, depression, anxiety, suicidality, and everyday stressors that might impede quality of life.
For more information about Dr. Beck's research on CT for schizophrenia, please click here.
For more information about our research on CT for schizophrenia please click here.
NRSA Postdoctoral Fellowship with Dr. Aaron T. Beck. Click here for information.